Search
for
Sort by
Research 331–360 of 441
- Periungual lesions secondary to chemotherapy with docetaxel
- Scalp Psoriasis
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- CLINICAL STUDY OF CUTANEOUS MANIFESTATION OF GERIATRIC AGE GROUP
- Contents Vol. 2, 2016
- Long-term treatment within a maximum of 96 weeks of tinea unguium with long-pulsed neodymium-doped yttrium aluminum garnet laser
- Incidence of alopecia from endocrine therapies in cancer
- Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment
- Onychomatricoma with classic features: Case report and review of the literature
- Dermatological manifestations associated with pregnancy
- Hair and Nails
- Hair loss: An epidemiologic approach
- Clinical interest of a nonchemical lotion in head lice management
- Trichoscopy: Usefulness in diagnosing hair loss in adult female patients
- Expression patterns of hair-related keratins and epithelial keratins in onychopapilloma: The significance of clarifying the origin of onychopapilloma
- The Complexities of Iron Deficiency in Patients After Bariatric Surgery
- Transverse Leukonychia and Beau Lines Following COVID-19 Vaccination
- When Rare Meets Risky: Clouston Syndrome with Cutaneous Squamous Cell Carcinoma
- Painful thickened skin on the soles of the feet
- Trachyonychia with juvenile pityriasis rubra pilaris
- Rapp-Hodgkin syndrome: A review of the aspects of hair and hair color
- Hormonal and Surgical Treatment Options for Transgender Women and Transfeminine Spectrum Persons
- Hemiagenesis of the thyroid gland detected by coincidence—what is the clinical relevance?
- Improved Transgender Care in the ED
- Lessons From Epcot and Orlando 2014
- Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women’s cancers. Results of a prospective study
- Genetic hair and nail disorders
- Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
- Sorafenib-Associated Facial Acneiform Eruption
- Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description